Posted on 07/09/2021 7:33:20 PM PDT by CheshireTheCat
The U.S. Food and Drug Administration (FDA) had asked for a federal investigation into its approval of a controversial Alzheimer's drug.
Dr Janet Woodcock, acting commissioner of the FDA, announced she sent a letter to the Office of Inspector General of the U.S. Department of Health & Human Services for a probe into communications between FDA staff and Biogen Inc representatives in the lead up to the approval of Aduhelm, the company's Alzheimer's drug.
'Given the ongoing interest and questions, today I requested that [The Office of the Inspector General] conduct an independent review and assessment of interactions between representatives of Biogen and FDA during the process that led to the approval of Aduhelm,' she wrote on Twitter on Friday.
Aduhelm received FDA approval on June 7 despite limited data that it worked in clinical trials....
(Excerpt) Read more at dailymail.co.uk ...
The large price tag of the drug has been a point of concern as
A year of treatment using the drug will cost $56,000 a year, a huge premium to the $10,000 to $20,000 the drug was expected to cost.
..,
An analysis published by the Kaiser Family Foundation estimated that if just 500,000 Medicare recipients are prescribed Aduhelm, it would cost Medicare nearly $29 billion a year, far more than any other medication.
—
This is insane.
I remember thinking "I wonder if I'll ever hear of this outfit again." Not too many years later, I did indeed hear of it again.
+10% to the Big Guy
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.